Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Challenges in designing and running smouldering myeloma interventional clinical trials.

Journal article

Lecat C. et al, (2024), EJHaem, 5, 418 - 420

Multiple myeloma and its treatment contribute to increased platelet reactivity.

Journal article

Mitchell JL. et al, (2023), Platelets, 34

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.

Journal article

Richardson PG. et al, (2023), N Engl J Med, 389, 1009 - 1022

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Journal article

Kurata K. et al, (2023), Blood Cancer J, 13

Flicking the switch in myeloma MRD.

Journal article

Watson E. and Ramasamy K., (2023), Blood, 141, 557 - 558

Load More